A strong family history may indicate you need to begin colorectal cancer screening earlier than the typically recommended age of 50, and you may need to be screened more frequently. 

"Being at FCCC has been a unique opportunity to continue my previous studies on the interaction of PARP-1 and damaged chromatin. My current work focuses on how nucleosomes are remodeled by PARP-1 near double-stranded DNA breaks, which is a completely new action for PARP-1. As PARP-1 is a recently approved therapeutic target in BRCA1-deficient breast and ovarian cancer, I believe that my findings will help improve existing anti-cancer therapies."

Cancer survivors share many things, including this: a fear that their cancer will return. It’s a worry that, ironically, often surfaces at what should be an occasion for relief—the end of active treatment. But that’s exactly when cancer survivors see their doctors less frequently and may feel adrift and anxious.